S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000 (ACP)
S0000D: A Study of the Effect of Vitamin E and/or Selenium on Adenomatous Colorectal Polyps (ACP) in Participants Enrolled in SELECT
RATIONALE: Studying tissue samples in the laboratory from participants receiving treatment on the Selenium and Vitamin E Cancer Prevention Trial (SELECT) SWOG-S0000 may help doctors predict a participant's response to treatment and help plan the best treatment.
PURPOSE: This phase III trial is studying the effect of vitamin E and/or selenium on colorectal polyps in men enrolled on SELECT Trial SWOG-S0000.
調査の概要
詳細な説明
OBJECTIVES:
Primary
- To assess the effect of selenium on colorectal adenoma (CRA) occurrence.
- To assess the effect of selenium on number, location, size, histologic type, and degree of dysplasia of CRA.
- To assess the effect of selenium on colorectal cancer (CRC) incidence.
Secondary
- To assess the effect of vitamin E on CRA occurrence.
- To assess the effect of vitamin E on CRC incidence.
Tertiary
- To explore the effect modification of selenium and vitamin E by aspirin on CRA occurrence.
- To explore the effect modification of selenium and vitamin E by body mass index.
OUTLINE: This is a multicenter study.
Endoscopically obtained tissue samples are reviewed by study pathologists to confirm the presence (or absence) of a colorectal adenoma (CRA). If a CRA is present, the number, location, size, histology, and degree of dysplasia are documented. The CRA is also reviewed to exclude a diagnosis of colorectal cancer.
Additional data, including aspirin use, height and weight, date of birth, and other demographic and baseline characteristics, is also obtained. Participants' medical records are reviewed periodically.
Participants are followed annually.
研究の種類
入学 (実際)
段階
- フェーズ 3
連絡先と場所
研究場所
-
-
Arizona
-
Tucson、Arizona、アメリカ、86724
- Arizona Cancer Center
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
DISEASE CHARACTERISTICS:
- Enrolled on the Selenium and Vitamin E Cancer Prevention Trial (SELECT) SWOG-S0000
- Screened by lower endoscopy (i.e., sigmoidoscopy and/or colonoscopy) after randomization on SELECT trial
PATIENT CHARACTERISTICS:
- Willing to sign an applicable medical records release form
- Willing to allow the release of tissue for central pathology review of resected polyps and endoscopic biopsies
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:防止
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:4倍
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Vitamin E + selenium placebo
Vitamin E and selenium placebo daily for 7 - 12 years
|
400 IU daily by mouth for 7 - 12 years
他の名前:
1 pill by mouth daily for 7 - 12 years
他の名前:
|
|
実験的:Selenium + vitamin E placebo
Selenium and vitamin E placebo daily for 7 - 12 years
|
200 mcg daily for 7 - 12 years
他の名前:
1 pill by mouth daily for 7 - 12 years
他の名前:
|
|
実験的:Vitamin E + selenium
Vitamin E and selenium daily for 7 - 12 years
|
400 IU daily by mouth for 7 - 12 years
他の名前:
200 mcg daily for 7 - 12 years
他の名前:
|
|
プラセボコンパレーター:Vitamin E placebo + selenium placebo
Vitamin E placebo and selenium placebo daily for 7 - 12 years
|
1 pill by mouth daily for 7 - 12 years
他の名前:
1 pill by mouth daily for 7 - 12 years
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Effect of Selenium on Colorectal Adenoma (CRA) Occurrence, Analyzed by Active Selenium vs. Selenium Placebo
時間枠:From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
|
|
Effect of Selenium on Advanced Neoplasia, Analyzed by Active Selenium vs. Selenium Placebo
時間枠:From 1 year post randomization through study completion
|
Adenomas with diameter >=1cm or any adenoma with villous features or high-grade dysplasia
|
From 1 year post randomization through study completion
|
|
Effect of Selenium and/or Vitamin E on Colorectal Cancer (CRC) Incidence
時間枠:From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
|
|
Effect of Selenium on Occurrences of Multiple (>2) Adenomas
時間枠:From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
Effect of Vitamin E on CRA Occurrence, Analyzed by Active Vitamin E vs. Vitamin E Placebo
時間枠:From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
その他の成果指標
結果測定 |
時間枠 |
|---|---|
|
Effect Modification of Selenium by Body Mass Index on CRA Occurrence, Analyzed by Active Selenium vs. Selenium Placebo
時間枠:From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
|
Effect Modification of Selenium by Aspirin on CRA Occurrence, Analyzed by Active Selenium vs. Selenium Placebo
時間枠:From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
|
Effect Modification of Vitamin E by Body Mass Index on CRA Occurence, Analyzed by Active Vitamin e vs. Vitamin e Placebo
時間枠:From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
|
Effect Modification of Vitamin E by Aspirin on CRA Occurrence, Analyzed by Active Vitamin e vs. Vitamin e Placebo
時間枠:From 1 year post randomization through study completion
|
From 1 year post randomization through study completion
|
協力者と研究者
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- CDR0000593329
- U10CA037429 (米国 NIH グラント/契約)
- S0000D (その他の識別子:SWOG)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。